Gland Pharma IPO allotment status: Two ways to check on BSE and Link Intime India

Gland Pharma IPO Allotment Status: Allotment of Shares for Gland Pharma IPO has started. The IPO is going to list on November 20 on the stock market.  The largest IPO of the Pharma company has received good response from investors. However, not all the investors who have subscribed for the share allotment will get the allotment. If investors have applied for the share, they have to check their allotment status to know whether they have got the allotment or no. Share allocation check can be done in 2 ways.

The IPO was subscribed 2.06 times: 

The Initial Public Offer (IPO) of Rs 6500 cr of Gland Pharma received good response from the investors. The issue was subscribed by 2.06 times. The share of retail investors got subscribed 24%, while the share on non-institutional investors got subscribed 51%. The company had set a price band of Rs 1490 – Rs 1500 per share for the IPO.

Option 1 from the BSE website: 

For this, first you have to go to the BSE website. After the equity box has been checked, then you have to enter the name of the issue in the dropdown, example: Gland Pharma. After that you have to type your application number in the box. After that you will have to provide information about your PAN Number. Finally, you have to click on the search button, after which the complete information will be revealed.  

Option 2: On the registrar’s website 

The registrar for this IPO is the Link Intime India, whose website has to be visited. The website is https://www.linkintime.co.in/IPO/public-issues.html. Type Company name Gland Pharma in the drop down, after that enter the PAN Number, application number or depository / client ID in the box. Then enter the captcha and click on the search button.
Note: In both the cases, if the allotment of the shares is final, then you will get information about your status.  

Drug Company’s Largest IPO: 

The Rs 6500 cr IPO is the largest IPO brought by any Pharmaceutical company. Earlier, Aris Lifesciences raised Rs 1741 cr from the IPO in 2017. Gland Pharma is originally promoted by Fosan Singapore and Shanghai Fosan Pharma. Gland Pharma manufactures injectable drugs. The company sells its products in 60 countries including India, UK, USA, Australia and Canada.